Microglial Cells in Neurodegenerative Diseases

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Neuroscience".

Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 4275

Special Issue Editor


E-Mail Website
Guest Editor
Medical School OWL, Anatomy and Cell Biology, Bielefeld University, 33615 Bielefeld, Germany
Interests: the mechanisms of TGF-beta-mediated modulation of microglia functions under physiological and pathological conditions; microglia development/maturation, microglia functions during postnatal CNS development, and microglia in the aged and diseased CNS are addressed using transgenic mouse models
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It has been shown that microglia significantly change their morphological and functional features during the course of neurodegenerative diseases, thereby contributing to the onset and progression of several CNS pathologies. However, whether microglia reactivity has beneficial or detrimental effects and consequences seems to depend on the particular disease. We aim to clarify the different microglia activation states found in distinct CNS pathologies and their contribution to disease outcomes.

Major questions are whether microglia are essential players for neurodegenerative processes and whether microglia depletion in vivo might be a therapeutic option for the treatment of neurodegenerative diseases. Furthermore, the understanding of how endogenous and/or exogenous factors or molecules regulate the reactivity of microglia in CNS diseases will be a major purpose of this Special Issue.

Submissions of original research and review manuscripts focusing on microglia activation and the role of microglia in neurodegenerative diseases of the brain and spinal cord are welcome. We hope to comprehensively summarize and elucidate the different microglia activation states related to neurodegeneration and hope to increase the overall understanding of microglia in neurodegenerative diseases.

Prof. Dr. Björn Spittau
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Microglia 
  • Neurodegenerative diseases 
  • Disease-associated microglia (DAM) 
  • Microglia activation 
  • Alzheimer's disease 
  • Parkinson's disease 
  • Ischemic stroke

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 5499 KiB  
Article
Morphology of Cortical Microglia in the Hyperacute Phase of Subarachnoid Hemorrhage
by Maksim Lyubomudrov, Anastasiya Babkina, Zoya Tsokolaeva, Mikhail Yadgarov, Sergey Shigeev, Dmitriy Sundukov and Arkady Golubev
Biology 2024, 13(11), 917; https://doi.org/10.3390/biology13110917 - 12 Nov 2024
Viewed by 406
Abstract
Hemorrhagic stroke is the deadliest type of stroke. Cellular and molecular biomarkers are important for understanding the pathophysiology of stroke. Microglia are among the most promising biological markers. However, the morphological and physiological characteristics of microglia, as well as the structural and functional [...] Read more.
Hemorrhagic stroke is the deadliest type of stroke. Cellular and molecular biomarkers are important for understanding the pathophysiology of stroke. Microglia are among the most promising biological markers. However, the morphological and physiological characteristics of microglia, as well as the structural and functional aspects of their interactions with neurons and other cells, are largely unknown. Due to the large number of different morphological phenotypes and very limited information on microglial changes in subarachnoid hemorrhage (SAH), we performed this study aimed at identifying the features of the distribution of various microglial phenotypes in the layers of the cerebral cortex in the hyperacute phase of non-traumatic SAH. We studied the distribution of various microglial phenotypes in the layers of the cerebral cortex of SAH non-survivors with a control group (coronary heart disease and sudden cardiac death were the underlying causes of death). An immunohistochemical study using antibodies to iba-1 (a marker of microglia) revealed changes in the morphological phenotypes of microglia in the cerebral cortex after subarachnoid hemorrhage. Significant differences between the groups indicate a rapid microglial response to injury. The findings indicate that there are quantitative and phenotypic changes in microglia in the cerebral cortex during early SAH in the human cortex. Full article
(This article belongs to the Special Issue Microglial Cells in Neurodegenerative Diseases)
Show Figures

Figure 1

12 pages, 1864 KiB  
Article
Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (Lilrb4) Expression in Microglia
by Felix Kretzschmar, Robin Piecha, Jannik Jahn, Phani Sankar Potru and Björn Spittau
Biology 2021, 10(12), 1300; https://doi.org/10.3390/biology10121300 - 9 Dec 2021
Cited by 5 | Viewed by 3049
Abstract
As resident innate immune cells of the CNS, microglia play important essential roles during physiological and pathological situations. Recent reports have described the expression of Lilrb4 in disease-associated and aged microglia. Here, we characterized the expression of Lilrb4 in microglia in vitro and [...] Read more.
As resident innate immune cells of the CNS, microglia play important essential roles during physiological and pathological situations. Recent reports have described the expression of Lilrb4 in disease-associated and aged microglia. Here, we characterized the expression of Lilrb4 in microglia in vitro and in vivo in comparison with bone marrow-derived monocytes and peritoneal macrophages in mice. Using BV2 cells, primary microglia cultures as well as ex vivo isolated microglia and myeloid cells in combination with qPCR and flow cytometry, we were able to provide a comprehensive characterization of Lilrb4 expression in distinct mouse myeloid cells. Whereas microglia in vivo display low expression of Lilrb4, primary microglia cultures present high levels of surface LILRB4. Among the analyzed peripheral myeloid cells, peritoneal macrophages showed the highest expression levels of Lilrb4. Moreover, LPS treatment and inhibition of microglial TGFβ signaling resulted in significant increases of LILRB4 cell surface levels. Taken together, our data indicate that LILRB4 is a reliable surface marker for activated microglia and further demonstrate that microglial TGFβ signaling is involved in the regulation of Lilrb4 expression during LPS-induced microglia activation. Full article
(This article belongs to the Special Issue Microglial Cells in Neurodegenerative Diseases)
Show Figures

Figure 1

Back to TopTop